Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp10025-33 Peptides

9Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

Identification and quantification of immunogenic peptides and tumor-derived epitopes presented on MHC-I molecules are essential for basic studies and vaccines generation. Although lymphocytes derived from transgenic mice can serve as sensitive detectors of processes of antigen presentation and recognition, they are not always available. The use of cell lines might be extremely useful. In this study, we generated a lacZ inducible CD8+ hybridoma (BUSA14) capable of recognizing both human and mouse gp10025-33 melanoma antigens presented on dendritic and tumor cell lines. This hybridoma expresses a variety of membranal T cell markers and secretes IL-2 and TNFα. Thus, BUSA14 offers a quantifiable, cheap and straightforward tool for studying peptide presentation by MHC-I molecules on the cell surface. © 2013 Cafri et al.

Cite

CITATION STYLE

APA

Cafri, G., Sharbi-Yunger, A., Tzehoval, E., & Eisenbach, L. (2013). Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp10025-33 Peptides. PLoS ONE, 8(2). https://doi.org/10.1371/journal.pone.0055583

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free